AHN 1-055 hydrochloride
CAS No. 202646-03-5
AHN 1-055 hydrochloride( 3α-Bis-(4-fluorophenyl) Methoxytropane hydrochloride )
Catalog No. M28222 CAS No. 202646-03-5
AHN 1-055 hydrochloride is an inhibitor of dopamine transporter (DAT) and dopamine uptake(IC50 = 71 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 46 | Get Quote |
|
10MG | 72 | Get Quote |
|
25MG | 147 | Get Quote |
|
50MG | 233 | Get Quote |
|
100MG | 349 | Get Quote |
|
200MG | 525 | Get Quote |
|
500MG | 788 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAHN 1-055 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAHN 1-055 hydrochloride is an inhibitor of dopamine transporter (DAT) and dopamine uptake(IC50 = 71 nM).
-
DescriptionAHN 1-055 hydrochloride is an inhibitor of dopamine transporter (DAT) and dopamine uptake(IC50 = 71 nM). AHN 1-055 hydrochloride may serve as a lead for the development of agents for the treatment of cocaine abuse.(In Vivo):In adult male Sprague Dawley rats, AHN 1-055 hydrochloride (5 mg/kg; i.v.) inhibited the uptaking of brain dopamine with an IC50 of 311.8 ng/ml. The Cmax and T1/2 are 1.48 mg/L and 7.69 h due to 1.8L/h/kg plasma clearance combined with 18.7 L/kg volumes of distribution.
-
In Vitro——
-
In VivoAnimal Model:Adult male Sprague Dawley rats (250-275 g)Dosage:5?mg/kg (Pharmacokinetic Analysis)Administration:I.v. administration Result:Cmax (1.48 mg/L); T1/2 (7.69 h).
-
Synonyms3α-Bis-(4-fluorophenyl) Methoxytropane hydrochloride
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorEGFR (wt)|EGFR (L858R)|EGFR (L861Q)|EGFR (L858R/T790M)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202646-03-5
-
Formula Weight379.87
-
Molecular FormulaC21H24ClF2NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (263.25 mM)
-
SMILESCN1[C@@H]2C[C@@H](OC(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)C[C@H]1CC2.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Luwei Han, et al. SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Front Pharmacol. 2021 Apr 27;12:665253.
molnova catalog
related products
-
Rotigotine
A non-selective agonist of the dopamine D3 receptor (Ki=0.71 nM); has 10-fold selectivity for the D3 receptor over the D2, D4, and D5 receptors and 100-fold selectivity for the D3 receptor over the D1 receptor.
-
Raclopride
Raclopride is a selective antagonist of dopamine D2/D3 receptor.
-
N-0500 HCl
N-0500 HCl is a very potent centrally acting DA receptor agonist. N-0500 HCl is a potent displacer of the specific [3H]DP_x005f5,6-ADTN binding with IC50 of 3nM.